| 股號 / 名稱 | 總負債 | 淨值 |
| MDT 美敦力 | 39,044,000,000.0 | 51,792,000,000.0 |
| SYK 史賽克 | 21,319,000,000.0 | 18,593,000,000.0 |
| ZBH Zimmer Biomet Holdings Inc | 9,016,500,000.0 | 12,480,400,000.0 |
| BIO Bio Rad Laboratories Inc | 3,557,937,000.0 | 8,741,133,000.0 |
| QDEL QuidelOrtho Corp | 3,557,200,000.0 | 5,005,900,000.0 |
| RMD 瑞思邁 | 2,184,642,000.0 | 4,629,920,000.0 |
| NVST Envista Holdings Corp | 2,431,200,000.0 | 4,173,900,000.0 |
| NEOG Neogen Corp | 1,436,318,000.0 | 3,146,174,000.0 |
| ICUI ICU Medical Inc | 2,255,029,000.0 | 2,123,410,000.0 |
| OMI Owens & Minor Inc | 4,169,156,000.0 | 924,166,000.0 |
| EYE National Vision Holdings Inc | 1,343,093,000.0 | 829,418,000.0 |
| INMD Inmode Ltd | 75,914,000.0 | 787,372,000.0 |
| HCM HUTCHMED (China) Ltd | 549,232,000.0 | 730,541,000.0 |
| ATRC AtriCure Inc | 147,764,000.0 | 466,168,000.0 |
| MRVI Maravai LifeSciences Holdings Inc | 1,070,697,000.0 | 416,753,000.0 |
| QTRX Quanterix Corp | 78,084,000.0 | 346,927,000.0 |
| BLFS BioLife Solutions Inc | 75,051,000.0 | 337,663,000.0 |
| WRBY Warby Parker Inc | 278,525,000.0 | 301,787,000.0 |
| PAHC Phibro Animal Health Corp | 701,905,000.0 | 270,803,000.0 |
| PETQ PetIQ Inc | 647,013,000.0 | 221,213,000.0 |
| CMRX Chimerix Inc | 19,745,000.0 | 193,029,000.0 |
| ORMP Oramed Pharmaceuticals Inc | 56,730,000.0 | 163,821,000.0 |
| TGTX TG Therapeutics Inc | 169,085,000.0 | 160,502,000.0 |
| MGNX MacroGenics Inc | 145,805,000.0 | 152,613,000.0 |
| UTMD Utah Medical Products Inc | 7,145,000.0 | 128,313,000.0 |
| SRDX Surmodics Inc | 58,090,000.0 | 122,150,000.0 |
| VMD Viemed Healthcare Inc | 41,000,000.0 | 113,895,000.0 |
| QIPT Quipt Home Medical Corp | 133,296,000.0 | 110,597,000.0 |
| ZVIA Zevia PBC | 979,000.0 | 89,878,000.0 |
| CERS Cerus Corp | 145,098,000.0 | 52,650,000.0 |
| VERU Veru Inc | 28,964,610.0 | 51,602,270.0 |
| ZYXI Zynex Inc | 90,775,000.0 | 46,129,000.0 |
| APYX Apyx Medical Corp | 52,539,000.0 | 26,701,000.0 |
| ICCC ImmuCell Corp | 18,815,030.0 | 24,993,080.0 |
| CTSO Cytosorbents Corp | 29,985,470.0 | 23,275,160.0 |
| XGN Exagen Inc | 34,250,000.0 | 22,694,000.0 |
| CAPR Capricor Therapeutics Inc | 36,132,860.0 | 22,601,470.0 |
| NURO NeuroMetrix Inc | 1,333,120.0 | 20,091,320.0 |
| HUGE FSD Pharma Inc | 4,238,070.0 | 13,236,760.0 |
| UG United-Guardian Inc | 1,534,260.0 | 11,388,580.0 |
| NEPH Nephros Inc | 3,503,000.0 | 8,358,000.0 |
| GHSI Guardion Health Sciences Inc | 3,772,130.0 | 8,146,040.0 |
| FLGC Flora Growth Corp | 17,222,000.0 | 6,404,000.0 |
| SNES Senestech Inc | 942,000.0 | 6,351,000.0 |
| GCTK GlucoTrack Inc | 1,708,000.0 | 3,197,000.0 |
| CLRB Cellectar Biosciences Inc | 13,431,630.0 | -1,356,050.0 |
| LFLY Leafly Holdings Inc | 34,293,000.0 | -12,458,000.0 |
| EOLS Evolus Inc | 209,687,000.0 | -20,689,000.0 |
| TRIB Trinity Biotech PLC | 83,384,000.0 | -23,949,000.0 |
| OMER Omeros Corp | 403,252,000.0 | -24,983,000.0 |
| BRBR Bellring Brands Inc | 1,002,400,000.0 | -286,900,000.0 |
載入數據中...
最新要聞
和醫療產品相關的產業概念股
醫療產品概念股相關指標排名
醫療產品每月營收
醫療產品每股盈餘
醫療產品每股淨值
醫療產品損益表
醫療產品總資產
醫療產品負債和股東權益
醫療產品現金流量表
醫療產品利潤比率
醫療產品營業費用率拆解
醫療產品杜邦分析
醫療產品ROE / ROA
醫療產品經營週轉能力
醫療產品營運週轉天數
醫療產品現金股利發放率
醫療產品財務結構比率
醫療產品流速動比率
醫療產品利息保障倍數
醫療產品現金流量分析
醫療產品營業現金流對淨利比
醫療產品盈餘再投資比率
醫療產品月營收成長率
醫療產品營收成長率
醫療產品毛利成長率
醫療產品營業利益成長率
醫療產品稅後淨利成長率
醫療產品每股盈餘成長率
醫療產品本益比評價
醫療產品股價淨值比評價
醫療產品現金股利殖利率
醫療產品平均現金股息殖利率
醫療產品董監持股比例
醫療產品董監持股質押比例